CN104151225A - 3,5-dimethyl-1H-pyrrole-2,4-biformaldehyde and preparation method thereof - Google Patents

3,5-dimethyl-1H-pyrrole-2,4-biformaldehyde and preparation method thereof Download PDF

Info

Publication number
CN104151225A
CN104151225A CN201310179529.XA CN201310179529A CN104151225A CN 104151225 A CN104151225 A CN 104151225A CN 201310179529 A CN201310179529 A CN 201310179529A CN 104151225 A CN104151225 A CN 104151225A
Authority
CN
China
Prior art keywords
compound
dimethyl
reaction solution
hour
room temperature
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201310179529.XA
Other languages
Chinese (zh)
Inventor
王帮臣
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TIANJIN HEOWNS BIOCHEMISTRY TECHNOLOGY Co Ltd
Original Assignee
TIANJIN HEOWNS BIOCHEMISTRY TECHNOLOGY Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TIANJIN HEOWNS BIOCHEMISTRY TECHNOLOGY Co Ltd filed Critical TIANJIN HEOWNS BIOCHEMISTRY TECHNOLOGY Co Ltd
Priority to CN201310179529.XA priority Critical patent/CN104151225A/en
Publication of CN104151225A publication Critical patent/CN104151225A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/333Radicals substituted by oxygen or sulfur atoms

Abstract

The invention relates to a compound 3,5-dimethyl-1H-pyrrole-2,4-biformaldehyde and a preparation method thereof. According to the method, 3,5-dimethyl-1H-pyrrole-2,4-biformaldehyde with a complicated structure is synthesized from the raw materials such as ethyl acetoacetate and acetic acid for the first time, the yield of the prepared final product can be up to 38%, the 3,5-dimethyl-1H-pyrrole-2,4-biformaldehyde is good in crystallization effect and high in purity, and high-purity guide samples and samples are provided for subsequent chemical and biological equipments. The invention also provides a detailed synthesis and purification method of the 3,5-dimethyl-1H-pyrrole-2,4-biformaldehyde. The production method is scientific and reasonable, so as to provide detailed theoretical and practical guidance for subsequent expanded production.

Description

3,5-dimethyl-1H-pyrroles-2,4-dicarbaldehyde and preparation method thereof
Technical field
The invention belongs to compound preparation field, especially a kind of 3,5-dimethyl-1H-pyrroles-2,4-dicarbaldehyde and preparation method thereof.
Background technology
At present, because Bioexperiment makes new breakthroughs, make us in treatment and find in the process of the cause of disease, means are more, result is more accurate, property pharmaceutical requirements is also increased gradually for the various diseases for the treatment of so, therefore, the various compounds with new function are in a large amount of being developed, the whole world all has the new compound of the various difficult and complicated cases of opposing in searching, so in the process of these new compound exploitations, can produce the compound of numerous new textures and new configuration, and then in these numerous new compounds, find useful, there is the molecule for the treatment of use, therefore developing new compound is one and important process.
Summary of the invention
The object of the present invention is to provide a kind of brand-new compound 3,5-dimethyl-1H-pyrroles-2,4-dicarbaldehyde and preparation method, the present invention is synthetic and this compound of purifying first, make its purity reach certain requirement, can further test or application it.
The object of the invention is to be achieved through the following technical solutions:
Compound 3,5-dimethyl-1H-pyrroles-2,4-dicarbaldehyde, its structural formula is as follows:
The preparation method of this compound is as follows:
(1) compound 2 is synthetic
In the time of 10 DEG C, will in the acetum of methyl aceto acetate, drip sodium nitrite in aqueous solution, continue reaction 1 hour, reaction solution is heated to room temperature and under violent stirring, adds zinc powder.Reaction solution is refluxed 1 hour, after TLC detection reaction finishes, reaction solution is poured into water, stirring was filtered after half an hour.Filter cake washes with water three times, is at room temperature dried and obtains faint yellow solid powder in 12 hours, is compound 2.
The mol ratio of described methyl aceto acetate, Sodium Nitrite, zinc powder is 1.3:0.7:1.31; The acetum concentration of described methyl aceto acetate is: every 1.3mol methyl aceto acetate adopts 500ml acetate dissolution.
(2) compound 3 is synthetic
Compound 2 is suspended in potassium hydroxide aqueous solution, and backflow is spent the night.After TLC detection reaction finishes, reaction solution is cooled under the stirring of room temperature ice bath and adds concentrated hydrochloric acid, regulate pH to stir 1 hour to acid., be extracted with ethyl acetate three times to neutral with saturated potassium carbonate regulator solution, merge organic phase dried over sodium sulfate, filter, be spin-dried for and obtain dark-brown oily liquids.80 DEG C of underpressure distillation obtain white transparent liquid compound 3.
Described compound 2 is 0.3:2 with the mol ratio of potassium hydroxide.
(3) compound 3,5-dimethyl-1H-pyrroles-2,4-dicarbaldehyde synthetic
Compound 3 is dissolved in DMF, and slowly the slow phosphorus oxychloride that drips, at room temperature stirs and spends the night.Reaction solution is slowly poured in frozen water, regulates pH=8 with saturated potassium carbonate, and ethyl acetate extraction three times merges organic relevant dry filtration and is spin-dried for and obtains thick product.Obtain product with PE:EA recrystallization.
Described compound 3 is 4:9 with the mol ratio of phosphorus oxychloride; The concentration that described compound 3 is dissolved in DMF is: every 40mmol compound 3 adopts 25mlDMF to dissolve.
The structural formula of described compound 2 is the structural formula of described compound 3 is
Advantage of the present invention and positively effect are:
1, the present invention uses the raw material such as methyl aceto acetate, acetic acid to synthesize first to have 3 of complex construction, 5-dimethyl-1H-pyrroles-2,4-dicarbaldehyde, prepare the productive rate of end product up to 38%, and crystallization effect is good, purity is high, for follow-up chemistry and Bioexperiment provide highly purified standard specimen or sample.
2, the present invention also provides 3,5-dimethyl-1H-pyrroles-2, the synthetic and purification process that 4-dicarbaldehyde is detailed, and production method science, reasonable, instructs for follow-up expanding production provides detailed theory and practice.
3, the invention provides 3,5-dimethyl-1H-pyrroles-2, synthesis condition, the raw material of each step in 4-dicarbaldehyde building-up process, and the nuclear magnetic spectrum of synthetic after product, for the analysis and identification of intermediate product in building-up process provides detailed support.
Brief description of the drawings
Fig. 1 is the nuclear-magnetism figure of the compounds of this invention 2, 1h NMR (300MHz, D2O);
Fig. 2 is the nuclear-magnetism figure of the compounds of this invention 3, 1h NMR (300MHz, D2O);
Fig. 3 is the compounds of this invention 3,5-dimethyl-1H-pyrroles-2, and the nuclear-magnetism figure of 4-dicarbaldehyde, 1hNMR (300MHz, D2O).
Embodiment
Below in conjunction with embodiment, the present invention is further described, and following embodiment is illustrative, is not determinate, can not limit protection scope of the present invention with following embodiment.
Reaction scheme of the present invention is as follows:
Raw material
The raw materials such as methyl aceto acetate are market and buy, without particular requirement.
The synthetic method of this compound is as follows:
(1) compound 2 is synthetic
In the time that 10 spend, will in the acetic acid of methyl aceto acetate (1.3mol) (500mL) solution, drip the aqueous solution of Sodium Nitrite (0.7mol), continue reaction hour, reaction solution is heated to room temperature and under violent stirring, adds zinc powder (1.31mol).Reaction solution is refluxed one hour, and TLC detection reaction finishes.Reaction solution is poured into water, and stirring was filtered after half an hour.Filter cake washes with water three times, at room temperature the dry faint yellow solid powder 80g that obtains for 12 hours.
(2) compound 3 is synthetic
By 2,4-dimethyl pyrrole-3,5-diethyl dicarboxylate (0.3mol) is suspended in the aqueous solution of potassium hydroxide (2mol), and backflow is spent the night.TLC detects, and after reaction finishes, reaction solution is cooled under the stirring of room temperature ice bath and adds concentrated hydrochloric acid, regulates pH to stir one hour to acid., be extracted with ethyl acetate three times to neutral with saturated potassium carbonate regulator solution, merge organic phase dried over sodium sulfate, filter, be spin-dried for and obtain dark-brown oily liquids.80 DEG C of underpressure distillation obtain white transparent liquid 2,4-dimethyl pyrrole (11.5g, 36.2%).
(3) 3,5-dimethyl-1H-pyrroles-2,4-dicarbaldehyde synthetic
2,4-dimethyl pyrrole (40mmol) is dissolved in DMF (25mL), and slowly the slow phosphorus oxychloride (90mmol) that drips, then at room temperature stirs and spends the night.Reaction solution is slowly poured in frozen water, regulates pH=8 with saturated potassium carbonate, and ethyl acetate extraction three times merges organic relevant dry filtration and is spin-dried for and obtains thick product.Obtain product 2.7g, productive rate 38% with PE:EA recrystallization.

Claims (4)

1. a compound 3,5-dimethyl-1H-pyrroles-2,4-dicarbaldehyde, is characterized in that: structural formula is as follows:
2. the preparation method of compound according to claim 1, is characterized in that: step is as follows:
(1) compound 2 is synthetic
In the time of 10 DEG C, will in the acetum of methyl aceto acetate, drip sodium nitrite in aqueous solution, continue reaction 1 hour, reaction solution is heated to room temperature and under violent stirring, adds zinc powder.Reaction solution is refluxed 1 hour, after TLC detection reaction finishes, reaction solution is poured into water, stirring was filtered after half an hour.Filter cake washes with water three times, is at room temperature dried and obtains faint yellow solid powder in 12 hours, is compound 2.
The mol ratio of described methyl aceto acetate, Sodium Nitrite, zinc powder is 1.3:0.7:1.31; The acetum concentration of described methyl aceto acetate is: every 1.3mol methyl aceto acetate adopts 500ml acetate dissolution.
(2) compound 3 is synthetic
Compound 2 is suspended in potassium hydroxide aqueous solution, and backflow is spent the night.After TLC detection reaction finishes, reaction solution is cooled under the stirring of room temperature ice bath and adds concentrated hydrochloric acid, regulate pH to stir 1 hour to acid., be extracted with ethyl acetate three times to neutral with saturated potassium carbonate regulator solution, merge organic phase dried over sodium sulfate, filter, be spin-dried for and obtain dark-brown oily liquids.80 DEG C of underpressure distillation obtain white transparent liquid compound 3.
Described compound 2 is 0.3:2 with the mol ratio of potassium hydroxide.
(3) compound 3,5-dimethyl-1H-pyrroles-2,4-dicarbaldehyde synthetic
Compound 3 is dissolved in DMF, and slowly the slow phosphorus oxychloride that drips, at room temperature stirs and spends the night.Reaction solution is slowly poured in frozen water, regulates pH=8 with saturated potassium carbonate, and ethyl acetate extraction three times merges organic relevant dry filtration and is spin-dried for and obtains thick product.Obtain product with PE:EA recrystallization.
Described compound 3 is 4:9 with the mol ratio of phosphorus oxychloride; The concentration that described compound 3 is dissolved in DMF is: every 40mmol compound 3 adopts 25mlDMF to dissolve.
3. preparation method according to claim 2, is characterized in that: the structure of described compound 2 is as follows:
4. preparation method according to claim 2, is characterized in that: the structure of described compound 3 is as follows:
CN201310179529.XA 2013-05-15 2013-05-15 3,5-dimethyl-1H-pyrrole-2,4-biformaldehyde and preparation method thereof Pending CN104151225A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310179529.XA CN104151225A (en) 2013-05-15 2013-05-15 3,5-dimethyl-1H-pyrrole-2,4-biformaldehyde and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310179529.XA CN104151225A (en) 2013-05-15 2013-05-15 3,5-dimethyl-1H-pyrrole-2,4-biformaldehyde and preparation method thereof

Publications (1)

Publication Number Publication Date
CN104151225A true CN104151225A (en) 2014-11-19

Family

ID=51876887

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310179529.XA Pending CN104151225A (en) 2013-05-15 2013-05-15 3,5-dimethyl-1H-pyrrole-2,4-biformaldehyde and preparation method thereof

Country Status (1)

Country Link
CN (1) CN104151225A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105418476A (en) * 2015-12-12 2016-03-23 常州大学 Synthesis method for 2-formyl-3,4-dimethyl-5-acetyl pyrrole

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105418476A (en) * 2015-12-12 2016-03-23 常州大学 Synthesis method for 2-formyl-3,4-dimethyl-5-acetyl pyrrole

Similar Documents

Publication Publication Date Title
CN103524440B (en) The preparation method of gout therapertics Lesinurad and Lesinurad intermediate
CN106631960A (en) Method for synthesizing oxiracetam
CN104447600A (en) Preparation method of parecoxib sodium compound as well as intermediate impurity and application of parecoxib sodium compound
CN102249974B (en) Preparation method of (s)-4-hydroxy-2-oxo-1-pyrrolidineacetamide
CN103183716A (en) Preparation method of tauro ursodesoxy cholic acid
CN103923087B (en) A kind of preparation method of deuterium-labeled sitagliptin
CN103694223B (en) A kind of one kettle way prepares the method for esomeprazole magnesium
CN102887851B (en) Compound 3,5-dimethyl-1H-pyrrole-2,4-diformaldehyde and preparation method thereof
CN104151225A (en) 3,5-dimethyl-1H-pyrrole-2,4-biformaldehyde and preparation method thereof
CN103923040B (en) A kind of method preparing furfural oxime acid
CN103772189B (en) Synthesis method of diethylstilbestrol compound methyl pigeon pea ketonic acid A
CN103709174B (en) The one-step synthesis of the bromo-3H-oxazole of 6-also [4,5-b] pyridin-2-ones
CN106883192B (en) The synthetic method of the benzoic acid derivative of nitrogenous class heterocyclic antineoplastic pharmaceutical actives oxazolyl modification
CN105884644A (en) Advantage forms and preparation method of neutral endopeptidase inhibitor salt
CN102010345B (en) Method for preparing D-phenylalanine through dynamic kinetic resolution
CN108033948A (en) A kind of preparation of De Lasha stars and its intermediate
CN103351346A (en) Preparation method of impurity HP1 in bendamustine hydrochloride
CN104459015B (en) A kind of method detecting sulfuric acid one methyl esters (sodium) content
CN103224437A (en) Amino acid methyl ester hydrochloride preparation
CN104177271B (en) A kind of preparation method of ALC
CN104447776A (en) Novel heterocyclic organic compound and preparation method thereof
CN105061421A (en) Method for preparing 2-chloro-1, 8-naphthyridine derivative
CN104151185A (en) N-(2,4-dimethyl phenyl)-3-hydroxyl-2-naphthamide and preparation method thereof
CN104140388A (en) Compound N-hydroxyl sulfo succinimide sodium and preparation method thereof
CN103896919A (en) Preparation method of deuterium-substituted dabigatran etexilate

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20141119